Live Breaking News & Updates on முடுக்கப்பட்ட ஒப்புதல்

Stay updated with breaking news from முடுக்கப்பட்ட ஒப்புதல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Fast Track Designation by the US FDA for the Treatment of Relapsed/Refractory Unresectable or Metastatic Melanoma

Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Fast Track Designation by the US FDA for the Treatment of Relapsed/Refractory Unresectable or Metastatic Melanoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states , China , Australia , Hong-kong , Rockville , Western-australia , Suzhou , Jiangsu , American , Dajun-yang , Ascentage-pharma , Major-national

News - Regulation, Focus On, Switzerland

News - Regulation, Focus On, Switzerland
thepharmaletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepharmaletter.com Daily Mail and Mail on Sunday newspapers.

China , Australia , Japan , Denmark , United-kingdom , Switzerland , Danish , Swiss , Roche-evrysdi , Roche-actemra-roactemra , Roche-enspryng , Australia-therapeutic-goods-administration

U.S. FDA Grants Key Approvals to Potential Rare and Serious Disease Treatments

The U.S. FDA has been actively greenlighting a number of efforts over the last few days to push therapies for rare or serious diseases that have largely unmet medical needs. Here's a look. ....

Bridgebio-pharma , Daniel-burgess , Douglas-sproule , Jim-doherty , Drug-administration , Ml-bio-solutions , Fast-track , Track-designation , Orphan-drug , Qualified-infectious-disease-production , Limb-girdle-muscular-dystrophy-type , Accelerated-approval

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United-states , Japan , South-korea , Singapore , Garret-hampton , J-thorac-oncolo , Mauricio-minotta , Dion-warren , Unity-lab-services , Drug-administration , Thermo-fisher , Japan-ministry-of-health

Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for EXKIVITY

Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for EXKIVITY
entrepreneur.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from entrepreneur.com Daily Mail and Mail on Sunday newspapers.

United-states , Boston , Massachusetts , Japan , South-korea , Fisher-cdx , Eli-lilly , Zacks-investment-research , Thermo-fisher , Laboratories-inc , View-research , Semler-scientific-inc